Format

Send to

Choose Destination
See comment in PubMed Commons below
Biochim Biophys Acta. 2014 Jul;1841(7):963-9. doi: 10.1016/j.bbalip.2014.03.011. Epub 2014 Apr 2.

Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter.

Author information

1
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, United States.
2
Division of Nutritional Science, Cornell University, Ithaca, NY 14853, United States.
3
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, United States; Department of Human Genetics, University of California, Los Angeles, CA 90095, United States. Electronic address: sgyoung@mednet.ucla.edu.
4
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, United States. Electronic address: abeigneux@mednet.ucla.edu.

Abstract

The S447X polymorphism in lipoprotein lipase (LPL), which shortens LPL by two amino acids, is associated with low plasma triglyceride levels and reduced risk for coronary heart disease. S447X carriers have higher LPL levels in the pre- and post-heparin plasma, raising the possibility that the S447X polymorphism leads to higher LPL levels within capillaries. One potential explanation for increased amounts of LPL in capillaries would be more avid binding of S447X-LPL to GPIHBP1 (the protein that binds LPL dimers and shuttles them to the capillary lumen). This explanation seems plausible because sequences within the carboxyl terminus of LPL are known to mediate LPL binding to GPIHBP1. To assess the impact of the S447X polymorphism on LPL binding to GPIHBP1, we compared the ability of internally tagged versions of wild-type LPL (WT-LPL) and S447X-LPL to bind to GPIHBP1 in both cell-based and cell-free binding assays. In the cell-based assay, we compared the binding of WT-LPL and S447X-LPL to GPIHBP1 on the surface of cultured cells. This assay revealed no differences in the binding of WT-LPL and S447X-LPL to GPIHBP1. In the cell-free assay, we compared the binding of internally tagged WT-LPL and S447X-LPL to soluble GPIHBP1 immobilized on agarose beads. Again, no differences in the binding of WT-LPL and S447X-LPL to GPIHBP1 were observed. We conclude that increased binding of S447X-LPL to GPIHBP1 is unlikely to be the explanation for more efficient lipolysis and lower plasma triglyceride levels in S447X carriers.

KEYWORDS:

GPIHBP1; Lipoprotein lipase; Triglyceride metabolism

PMID:
24704550
PMCID:
PMC4212522
DOI:
10.1016/j.bbalip.2014.03.011
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center